Investors

Press Releases

Endonovo Therapeutics Announces Registration Statement on Form S-1 has been Declared Effective
Endonovo Therapeutics Issues Corporate Update
Endonovo Therapeutics Receives Notice of Termination of Its Binding-Letter Agreement to Acquire Rio Grande Neurosciences
Endonovo Therapeutics Files Patent for Treating Chemical and Radiation Injuries Using Next-Generation Biologics
Endonovo Therapeutics Announces Issuance of U.S. Patent on Production of Human Biomolecules
Endonovo Therapeutics Announces New Round of Financing
Endonovo Therapeutics Announces Binding Letter of Intent to Acquire Rio Grande Neurosciences, Inc.
Endonovo Therapeutics Files Continuation Patent for Producing Adult Stem Cell Secretome
Endonovo Therapeutics Awarded Preliminary Injunction Against Kodiak Capital et al
Endonovo Therapeutics Provides Update on Variable Convertible Notes
RSS
Show All